Here you will find the links to the relevant studies for the use of Geistlich TauroSept^®. These links lead to external websites. Please note that some studies can only be downloaded in connection with a registration on the respective website.

• Activities of Taurolidine In Vitro and in Experimental Enterococcal Endocarditis
• Taurolidine: In vitro Activity against Mulitple-Antibiotic-Resistance
• Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locks
• Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients
• Indikationsspektrum und perioperatives Management bei i.v.-Portsystemexplantation - Alternative Taurolingabe bei i. v.-Portsysteminfektion
• The effect of taurolidine on experimental thrombus formation
• Hemmung der Staphylokokken-Koagulase durch Taurolin
• The Pharmacokinetics of Taurolidine Metabolites in Healthy Volunteers
• Taurolidine Lock is iuperior to Heparin Lock in the Prevention of Catheter Related Bloodstream Infections and Occlusions
• Incidence of central venous catheter related bloodstream infections in andults and children on home parenteral nutrition: Heparin versus Taurolidine catheter lock
• Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition
• Taurolidine lock: The key to prevention of recurrent catheter-related bloodstream infections
• Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition Clinical and economic impact of the taurolidine lock on home parenteral nutrition
• ESPEN guidelines on chronic intestinal failure in adults
• KRINKO Prävention von Infektionen, die von Gefäßkathetern ausgehen